Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHA:603882)
China · Delayed Price · Currency is CNY 23.41
-0.61 (-2.54%)
Jun 8, 2026, 3:00 PM CST
SHA:603882 Stock Forecast
Stock Price Forecast
According to 8 analysts polled by S&P Global, SHA:603882 stock has a consensus rating of "Buy" and an average price target of ¥30.49. The average 1-year stock price forecast is 30.24% higher than the current stock price, while the lowest is ¥22.00 (-6.02%) and the highest is ¥36.62 (+56.43%).
Price Target: ¥30.49 (+30.24%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for SHA:603882 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 4 | 4 | 5 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 2 | 2 | 2 | 2 | 2 | 2 |
| Total | 8 | 8 | 8 | 7 | 7 | 8 |
Financial Forecast
Revenue This Year
6.19B
from 6.03B
Increased by 2.62%
Revenue Next Year
7.04B
from 6.19B
Increased by 13.74%
EPS This Year
1.27
from -0.35
EPS Next Year
1.44
from 1.27
Increased by 13.51%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 6.5B | ||
| Avg | 6.2B | ||
| Low | 5.9B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 8.2% | ||
| Avg | 2.6% | ||
| Low | -2.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 1.27 | ||
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |